BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
94.11
-0.15 (-0.16%)
Jun 30, 2026, 10:16 AM EDT - Market open
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.8 billion as of June 30, 2026. Its market cap has decreased by -7.10% in one year.
Market Cap
23.80B
Enterprise Value
8.38B
1-Year Change
-7.10%
Ranking
Category
Stock Price
$94.11
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.80B, an increase of 694.63%. That is a compound annual growth rate of 36.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 23.80B | 3.96% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 32.38B |
| BeOne Medicines AG | 31.12B |
| Moderna | 26.69B |
| Roivant Sciences | 24.51B |
| Incyte | 22.73B |
| Insmed | 22.41B |
| Ascendis Pharma | 16.20B |
| Genmab | 15.94B |